(Q53527406)

English

Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Gassas A

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

Sung L

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

Saunders EF

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

Doyle J

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

language of work or name

0 references

publication date

17 September 2007

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

Bone Marrow Transplantation

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

40

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

10

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

951-955

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705853

0 references

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

21 January 2018

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

21 January 2018

Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

21 January 2018

Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

21 January 2018

Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

21 January 2018

The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705853

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705853

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17873916

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53527406&oldid=1525890252"